News & Updates

Innovative biodegradable biohybrid targeted therapy for intracranial tumours

The world’s first magnetically driven nonimmunogenic blood hydrogel fibre robot for treatment of deep-seated brain tumours have been successfully developed by a collaborative research team from the Chinese University of Hong Kong (CUHK), the Shenzhen University and the Shenzhen Institutes of Advanced Technology (SIAT).

Cough variant asthma: A diagnostic challenge with a simple solution

Long-term rectal cancer outcomes better with laparoscopic vs robotic surgery

Three-year data from the REAL study has shown that robot-assisted resection of middle or low rectal cancer is associated with lower locoregional recurrence and disease-free survival compared with the conventional laparoscopic approach.

V-ERAT trumps antibiotics for uncomplicated acute appendicitis

Patients with uncomplicated acute appendicitis may opt for visual endoscopic retrograde appendicitis therapy (V-ERAT) as a safe and effective alternative to antibiotic treatment to reduce the risk of recurrence, according to a study.

Is social media a reliable source of paediatric drug information?

Using social media to obtain relevant information is possible, with a recent study suggesting that data from child-rearing public parenting forums (CPPFs) may aid in assessing paediatric adverse drug events and in detecting unknown adverse drug reactions (ADRs) and medication errors.

HDL levels linked to AMD risk

Both high and low levels of high-density lipoprotein (HDL) are significantly associated with an elevated risk of age-related macular degeneration (AMD), reveals a study.

Efruxifermin misses mark in MASH-related compensated cirrhosis

Treatment with the bivalent fibroblast growth factor 21 (FGF21) analogue efruxifermin falls short of improving fibrosis in patients with compensated cirrhosis caused by metabolic dysfunction–associated steatohepatitis (MASH), according to a phase 2b study.

TRICH score predicts triple antihypertensive therapy need after ICH

A team from the LKS Faculty of Medicine at the University of Hong Kong (HKU) has developed an innovative clinical tool to help physicians effectively identify intracerebral haemorrhage (ICH) patients who would benefit from early initiation of triple antihypertensive therapy to reduce the risks of ICH recurrence and subsequent strokes.

Low-dose methotrexate of little benefit in knee OA with effusion-synovitis

In patients with knee osteoarthritis (OA) with effusion, the use of low-dose methotrexate does not appear to relieve pain or reduce effusion-synovitis, as reported in a study.